LABS.TO(LABS.TO)
LABS.TO
No analyst ratings available
No analyst price targets available for LABS.TO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $39M | $44M |
| Low | $39M | $44M |
| High | $39M | $44M |
| EBITDA Avg | $-21M | $-23M |
| Low | $-21M | $-23M |
| High | $-21M | $-23M |
| EBIT Avg | $-22M | $-25M |
| Low | $-22M | $-25M |
| High | $-22M | $-25M |
| Net Income Avg | $-4M | $-3M |
| Low | $-4M | $-3M |
| High | $-4M | $-3M |
| EPS Avg | $-0.01 | $-0.01 |
| Low | $-0.01 | $-0.01 |
| High | $-0.01 | $-0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $10M | $11M |
| Low | $10M | $11M |
| High | $10M | $11M |
| EBITDA Avg | $-5M | $-6M |
| Low | $-5M | $-6M |
| High | $-5M | $-6M |
| EBIT Avg | $-6M | $-6M |
| Low | $-6M | $-6M |
| High | $-6M | $-6M |
| Net Income Avg | $-679,782 | $-297,404 |
| Low | $-679,782 | $-297,404 |
| High | $-679,782 | $-297,404 |
| EPS Avg | $-0.00 | $-0.00 |
| Low | $-0.00 | $-0.00 |
| High | $-0.00 | $-0.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |